Q BioMed Ratios and Metrics

Market cap in millions USD. Fiscal year is December - November.

Millions USD. Fiscal year is Dec - Nov.

Fiscal Year	Current	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Feb '26 Feb 11, 2026	Nov '22 Nov 30, 2022	Nov '21 Nov 30, 2021	Nov '20 Nov 30, 2020	Nov '19 Nov 30, 2019	Nov '18 Nov 30, 2018
Market Capitalization	0	1	13	26	27	28
Market Cap Growth	-75.00%	-89.57%	-49.78%	-3.74%	-3.66%	-47.12%
Enterprise Value	-	10	20	32	31	27
Last Close Price	0.00	0.02	0.45	1.10	1.60	1.95
PS Ratio	0.07	4.75	66.12	858.39	-	-
PB Ratio	0.00	-0.29	-2.76	-23.94	-5.30	-262.64
P/OCF Ratio	0.01	0.70	-	-	-	-
EV/Sales Ratio	-	36.01	102.50	1057.67	-	-
Debt / Equity Ratio	-0.63	-0.89	-0.65	-0.09	-0.73	-27.18
Asset Turnover	0.11	0.13	0.27	0.05	-	-
Quick Ratio	0.00	0.01	0.08	0.10	0.03	6.25
Current Ratio	0.00	0.01	0.08	0.13	0.04	6.28
Return on Equity (ROE)	-	-	-	-	-	-7401.35%
Return on Assets (ROA)	-85.13%	-99.58%	-644.52%	-1300.21%	-261.26%	-280.17%
Return on Capital Employed (ROCE)	42.30%	74.60%	157.70%	1222.30%	174.40%	-325.90%
Earnings Yield	-13157.80%	-152.09%	-63.72%	-52.39%	-38.42%	-33.39%
Buyback Yield / Dilution	-130.36%	-67.13%	-20.84%	-47.34%	-9.50%	-31.23%

Updated Jun 16, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.